【self defense weapons for felons】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens
Sanofi
SNY will have to withdraw its heartburn drug,self defense weapons for felons Zantac, from U.S. markets, following FDA’s request.
The FDA has requested drugmakers marketing ranitidine, which is widely available by the brand name of Zantac, to immediately withdraw all prescription and OTC versions from the market. The FDA in its investigations observed that the ranitidine medications, which are approved for treating heartburn associated with acid indigestion, contain a carcinogenic contaminant, N-Nitrosodimethylamine ("NDMA").
Please note that in October 2019 Sanofi initiated a voluntary recall of all Zantac over-the-counter (“OTC”) versions — Zantac 150, Zantac 150 Cool Mint, and Zantac 75 — in the United States. The decision was made by the company as a precautionary measure following a public statement from the FDA in September, alerting about a possible contamination of ranitidine medications.
Due to recall of Zantac, Sanofi reported that sales of its Consumer Healthcare GBU declined 12.8% in the United States in the fourth quarter 2019. Complete withdrawal of the drug will further impact sales unfavorably in 2020. A few other generic drugmakers marketing ranitidine medications had also initiated voluntary recall of the drugs last year, including Perrigo PRGO and Lannett Company LCI.
Shares of Sanofi have lost 14.6% so far this year compared with the industry’s decrease of 11.1%.
Although low-levels of NDMA do not increase risk of cancer, the FDA has determined that NDMA in some ranitidine products increases with time and when medications are stored at higher than room temperatures. These can lead to consumer exposure to unacceptable levels of NDMA, which the agency states may cause cancer.
However, director of the FDA’s Center for Drug Evaluation and Research stated that though the agency had not observed unacceptable levels of NDMA in many of the samples that were tested, it was unsure of storage duration and conditions of the samples. Hence, as a precaution, the FDA decided that ranitidine medications should not be available to consumers and patients unless its quality can be assured.
With this withdrawal request, ranitidine medications will not be available for new or existing prescriptions or OTC use in the United States. The FDA has suggested alternative drugs for use, including famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (AstraZeneca’s AZN Nexium), lansoprazole (Takeda Pharmaceuticals’ Prevacid) or omeprazole (Prilosec). These medications are not found to contain NDMA.
Story continues
Sanofi Price
Sanofi Price
Sanofi price | Sanofi Quote
Zacks Rank
Sanofi currently carries a Zacks Rank #3 (Hold). You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Sanofi (SNY) : Free Stock Analysis Report
AstraZeneca PLC (AZN) : Free Stock Analysis Report
Perrigo Company plc (PRGO) : Free Stock Analysis Report
Lannett Co Inc (LCI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
(责任编辑:Hotspot)
- Here is Why Growth Investors Should Buy Brinker International (EAT) Now
- Voya: 3Q Earnings Snapshot
- A Sliding Share Price Has Us Looking At Malibu Boats, Inc.'s (NASDAQ:MBUU) P/E Ratio
- Euro zone manufacturing collapses in April as virus spreads -PMI
- What Can We Learn About FRP Holdings' (NASDAQ:FRPH) CEO Compensation?
- Omaha Public Facilities Corporation, NE -- Moody's assigns Aa2 to Omaha, NE's lease bonds; outlook stable
- Could coronavirus trigger a recession?
- Genesco (GCO) Gains But Lags Market: What You Should Know
- The Gross Law Firm Announces Class Actions on Behalf of Shareholders of QD, LK and ALGN
- Coronavirus spread in Canada is slowing - Public Health Agency
- Bitcoin Sees Record Number of Active Users as Price Almost Hits $20K
- Moving Average Crossover Alert: GoDaddy
- A Look At The Fair Value Of Leidos Holdings, Inc. (NYSE:LDOS)
- What Kind Of Shareholders Hold The Majority In Select Bancorp, Inc.'s (NASDAQ:SLCT) Shares?
- aTyr Pharma to Webcast Conference Call Reporting Third Quarter 2020 Financial Results - Management to host conference call and webcast on November 12th at 5:00 pm EST / 2:00 pm PST
- Genco Shipping & Trading (GNK) Lags Q3 Earnings and Revenue Estimates
- SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
- The TriNet Group (NYSE:TNET) Share Price Has Gained 256%, So Why Not Pay It Some Attention?
- Alaris Royalty Corp. to Host Earnings Call
- Stericycle (SRCL) Tops Q3 Earnings and Revenue Estimates